REGENXBIO Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for REGENXBIO Inc. (RGNX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.060.030.100.460.480.300.32
Short-Term Investments0.180.240.270.110.140.000.00
Cash & Short-Term Investments0.230.280.360.460.480.300.32
Accounts Receivable0.030.040.040.030.040.040.01
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.010.010.010.010.000.000.00
Total Current Assets0.280.330.420.520.530.350.34
Non-Current Assets
Property, Plant & Equipment (Net)0.170.190.210.190.120.040.03
Long-Term Investments0.010.040.200.390.050.000.00
Other Non-Current Assets0.010.010.010.010.010.010.00
Total Non-Current Assets0.190.240.420.600.180.150.21
Total Assets0.470.570.831.110.710.500.54
Current Liabilities
Accounts Payable0.020.020.030.010.010.010.02
Short-Term Debt0.030.050.050.040.020.000.00
Current Portion of Long-Term Debt0.030.050.050.040.020.000.00
Accrued Liabilities0.040.050.050.040.040.000.00
Deferred Revenue0.000.000.000.000.000.000.00
Other Current Liabilities0.000.000.000.080.070.020.00
Total Current Liabilities0.100.130.130.130.080.030.02
Non-Current Liabilities
Long-Term Debt0.030.040.090.080.070.010.01
Other Non-Current Liabilities0.000.010.010.040.000.000.00
Total Non-Current Liabilities0.100.130.240.260.250.010.01
Total Liabilities0.210.260.320.350.330.050.03
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-0.93-0.71-0.44-0.16-0.29-0.18-0.08
Accumulated Other Comprehensive Income0.000.00-0.020.000.000.000.00
Additional Paid-in Capital1.191.020.970.930.670.630.59
Shares Outstanding0.050.040.040.040.000.000.00
Total Stockholders' Equity0.260.310.520.760.380.450.51
Total Liabilities & Equity0.470.570.831.110.710.500.54